![H. Shepard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
H. Shepard
Fondateur chez
Enosi Life Sciences Corp.
Profil
H.
Michael Shepard was the founder of Receptor BioLogix, Inc. (founded in 2003, titles: President & Chief Scientific Officer) and Enosi Life Sciences Corp.
(founded in 2018, titles: President, Director & Chief Scientific Officer).
Former jobs include Independent Director at Nevis Brands, Inc., Principal at Genentech, Inc. (1980-1992), Chief Scientific Officer & Vice President at Halozyme Therapeutics, Inc. (2012-2017), President & Chief Scientific Officer at NewBiotics, Inc. (1997-2008), and Chief Scientific Officer & Vice President-Research at Canji, Inc. (1992-1997).
Education includes a doctorate from Indiana University and an undergraduate degree from the University of California, Davis.
Postes actifs de H. Shepard
| Sociétés | Poste | Début |
|---|---|---|
Enosi Life Sciences Corp.
 Enosi Life Sciences Corp. BiotechnologyHealth Technology Operates as a drug research and development company | Fondateur | 16/08/2018 |
Anciens postes connus de H. Shepard
| Sociétés | Poste | Fin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2017 |
Receptor BioLogix, Inc.
 Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Fondateur | 02/01/2008 |
NewBiotics, Inc.
 NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | President | 01/01/2008 |
Canji, Inc.
 Canji, Inc. Medical/Nursing ServicesHealth Services Gene therapy research | Directeur Technique/Scientifique/R&D | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Formation de H. Shepard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
NewBiotics, Inc.
NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Receptor BioLogix, Inc.
Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Health Technology |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Gene therapy research | Health Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nevis Brands, Inc.
 Nevis Brands, Inc. BiotechnologyHealth Technology Engages in the research on the field of immunotherapy | Health Technology |
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Operates as a drug research and development company | Health Technology |
